Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Device start-up Quanttus gets $3mm in seed funding

Executive Summary

Wearable monitoring device company Quanttus received $3mm in seed money from Khosla Ventures. Quanttus, founded in October 2012 out of technology from the Microsystem Technology Labs at the Massachusetts Institute of Technology, is designing a wrist-worn device which measures and collects clinical-grade heart rate, respiration, and blood pressure data, then applies algorithms to the information collected to provide insights about the wearer’s vital signs. It is intended for use by both healthy individuals wishing to better understand their overall health and learn about potential health risks, as well as by patients with chronic diseases, such as cardiovascular disease or diabetes, to monitor their condition.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies